Cocrystal Pharma, Inc. (COCP) vs Obsidian Therapeutics Inc. (OBX)

A side-by-side comparison of Cocrystal Pharma, Inc. and Obsidian Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COCP

Cocrystal Pharma, Inc.

$15M

$1.11HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT

OBX

Obsidian Therapeutics Inc.

$14M

$13.28HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — COCP vs OBX

growth of $100 · dividends reinvested · last 1y

COCP +20.6% (+20.6%/yr)OBX -20.9% (-20.9%/yr)COCP compounded faster over this window

COCP OBX

Metrics side by side

Total return (annualized)

Metric	COCP	OBX
Total return (1Y)	-8.23%	N/A
Total return CAGR (3Y)	-18.36%	N/A
Total return CAGR (5Y)	-37.50%	N/A
Total return CAGR (10Y)	-39.76%	N/A

OBX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full COCP analysis Full OBX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.